Edesa Biotech (EDSA) Tops Q1 EPS by 67c

Edesa Biotech (NASDAQ: EDSA) reported Q1 EPS of ($0.54), $0.67 better than the analyst estimate of ($1.21).

For earnings history and earnings-related data on Edesa Biotech (EDSA) click here.

You May Also Be Interested In

• The tech crown switches hands: Apple dethrones Nvidia as $4 trillion king
• Cohen & Steers (CNS) Tops Q2 EPS by 2c
• VIST Financial Corp. (VIST) Misses Q2 EPS by 76c